The intricate interplay between various oncogenes within the ERKp and its impact on the residual activity of wild-type or partial Loss-of-Function (LOF) p53, retained in tumors, which can potentially lead to tumor-suppressive effects, remains an area of ongoing investigation162,164. Here, TP53 is linked to neoplasm.